Description

Pregnil Powder for Solution for Injections 5000 IU Vial 1ml. №1

Ingredients:

Pregnyl contains the active ingredient chorionic gonadotropin (hCG) which is obtained from the urine of pregnant women.

Dosage:

Pregnil is administered by intramuscular or subcutaneous injection. The usual dosage is 5000-10000 IU once a day for the treatment of infertility in women.

Indications:

Pregnil is indicated for the treatment of infertility in women by inducing ovulation after other fertility treatments have failed.

Contraindications:

Pregnil is contraindicated in patients with hypersensitivity to hCG, precocious puberty, prostate cancer, and androgen-dependent tumors.

Directions:

Before using Pregnil, ensure proper aseptic technique during administration. Follow the recommended dosage and administration guidelines provided by your healthcare provider.

Scientific Evidence:

Studies have shown that hCG plays a crucial role in ovulation induction and fertility treatment. Research by Delvigne et al. (2016) demonstrated the efficacy of hCG in improving pregnancy rates in women undergoing assisted reproductive technologies.

Additional Information:

It is important to store Pregnil as per the instructions to maintain its efficacy. Consult your healthcare provider for proper usage and potential side effects associated with this medication.

Pharmacologically, hCG acts similarly to luteinizing hormone (LH) in the body, stimulating the release of eggs from the ovaries in women. This action is essential for fertility and is utilized in treatments for infertility.

Compared to similar drugs, Pregnil has shown comparable efficacy in inducing ovulation and improving pregnancy rates in women undergoing fertility treatments. Its reliable performance and established safety profile make it a preferred choice for many healthcare providers.